Skip to content

Guided Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence in Relapsing-Remitting Multiple Sclerosis

Assessment of the Effectiveness of Guided by a Physiotherapist Versus Non-guided Pelvic Floor Exercises for Urinary Incontinence (UI) in Patients With Relapsing-Remitting (RR) Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03000647
Enrollment
48
Registered
2016-12-22
Start date
2015-10-31
Completion date
2016-10-31
Last updated
2019-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsing-Remitting Multiple Sclerosis, Urinary Incontinence

Keywords

Pelvic floor muscle exercise, Supervision, Physiotherapy

Brief summary

The aim of the study is to evaluate the effectiveness of guided versus non guided pelvic floor exercises for urinary incontinence in patients with Relapsing-Remitting Multiple Sclerosis

Detailed description

Subjects of the study should conduct a specific training in pelvic floor exercises. They were randomly assigned into 2 groups: Group A only received written instructions for exercises to be performed at home; Group B received written instructions and, in addition, exercises were performed in a 30 minutes weekly session with a physiotherapist guiding them

Interventions

PROCEDUREPelvic floor exercises guided by a physiotherapist

Subjects perform two types of contractions of the pelvic floor in two different positions 3 times a day and once a week they check it with a physiotherapist (this day only they do it twice at home)

PROCEDURENon guided pelvic floor exercises

Subjects perform two types of contractions of the pelvic floor in two different positions 3 times a day. They do not attend to meetings with a physiotherapist

Sponsors

Universidad Rey Juan Carlos
CollaboratorOTHER
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with Relapsing-Remitting Multiple Sclerosis 2. Diagnosed with Urinary Incontinence 3. Minimental Sate Examination (MMSE) scale: More than 24 4. Expanded Disability Status Scale (EDSS) scale: Bladder function 0-4; EDSS 0-6,5 5. Willing to participate in the study 6. Having Signed an informed consent

Exclusion criteria

1. Diagnosed with another neurological disease 2. Diagnosed with kidney diseases 3. Having a Relapse of the disease in the last 6 months 4. In Women: Pregnancy os postpartum \< 6 months 5. Having gone through surgery for urinary incontinence or prolapses or prostate diseases 6. Having gone through other treatment for pelvic floor 7. MMSE scale: Under 24 8. EDSS scale: Bladder function 5-6 or not knowing; EDSS 7-10 9. ICIQ-SF scale: Severity 19-21 10. Not willing to participate or sign the informed consent form or not able to understand the study

Design outcomes

Primary

MeasureTime frameDescription
Decrease in the number of urinary leakages from baseline12 weeksDifference in the mean number of leakages (Registered for 3 days with a bladder diary)

Secondary

MeasureTime frameDescription
Decrease of urinary incontinence severity from baseline4,8 and 12 weeksComparison of the results: Questions 1, 2 and 3 of the International Consultation on Incontinence Questionnaire (ICIQ-SF) between the group 1 and 2
Change in quality of life from baseline4,8 and 12 weeksComparison of the results (Question 3 of the questionnaire ICIQ-SF and second part (13 questions) of the Overactive Bladder questionnaire (OABQ-SF) between the group 1 and 2
Decrease in the number of urinary leakages from baseline4 and 8 weeksComparison of the results (Registered for 3 days with a bladder diary) between the group 1 and 2
Lower urinary tract symptoms from baseline4,8 and 12 weeksComparison of de results (First part (6 questions) of the questionnaire OABQ-SF) between the group 1 and 2
Adherence12 weeksComparison of the results (Registered with exercise diary)between the group 1 and 2

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026